Recent developments in the radioimmunotherapy of cancer
- 31 December 1994
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 6 (5) , 715-721
- https://doi.org/10.1016/0952-7915(94)90074-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportNew England Journal of Medicine, 1993
- Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) AntibodyNew England Journal of Medicine, 1993
- Adjuvant therapy of ovarian cancer with radioactive monoclonal antibodyBritish Journal of Cancer, 1993
- Experimental radioimmunotherapyMedical Physics, 1993
- Pharmacokinetic modelingMedical Physics, 1993
- Selection of radionuclides for radioimmunotherapyMedical Physics, 1993
- Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgGBritish Journal of Cancer, 1992
- Monoclonal antibody-based therapies of leukemia and lymphomaBlood, 1992
- Man-made antibodiesNature, 1991
- A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.Journal of Clinical Oncology, 1990